Patient Acceptance of Rapid HIV Testing During Targeted Screening in the Emergency Department
Brianna N. McMonagle, Robert Braun, Jude Luke, Anita Goel, Caroline Freiermuth

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHIV/AIDS Research and Interventions · HIV, Drug Use, Sexual Risk · Syphilis Diagnosis and Treatment
Introduction
It is concerning that 12.8% of the 1.2 million individuals in the U.S. living with HIV are undiagnosed. It is important to identify these patients so those affected receive evidence-based treatment and prevent spread. The objective of this study is to estimate acceptance rates of free, point of care fingerstick HIV testing for a sample of targeted, at-risk individuals in the emergency department (ED). Additionally, we assess how test acceptance varies with demographics and categorize why patients decline HIV testing.
Methods
This is a single-center retrospective analysis of survey responses and documented HIV testing in a targeted sample of patients presenting to an urban academic ED in the Midwest from 2022–2023. The survey and testing were done by trained health promotion advocates, who perform targeted screening on a convenience sample of patients with social risk factors. We report the prevalence of testing acceptance and reasons for declining testing. Comparison of demographics between the overall ED population and those offered testing was done using a two sample T-test for age, and Chi-squared testing for all other variables. Logistic regression was done to find associations between test acceptance and demographic or risk factors.
Results
Over 24-months, 3,249 unique patients were offered point-of-care (POC) HIV tests and 1,680 (51.7%) accepted, per Table 1. African American patients and those identifying as males were offered testing at a greater frequency than their overall representation in the ED. African American patients were more likely to accept testing than white patients (54.3% vs. 47.8%, OR=1.28, p< 0.001), while increased age was associated with decreased test acceptance (OR=0.98 per year, p< 0.001), per Table 2. All patients who accepted belong to at least one population of interest including high-risk heterosexual behavior (40.4%), youth ages 13–29 (34.9%), and women of color (25.8%). The most common reasons cited by patients who declined testing were not wanting to be interviewed (24%) and having a prior negative test within the last 3 months (19.1%).
Conclusions
Over half of those offered POC testing for HIV in the ED accepted, with a significant percentage of those who declined reporting recent negative testing. Younger age and African American ethnicity were associated with a higher acceptance rate. Adopting an opt-out screening system and addressing common reasons for declining testing may provide opportunities for increasing HIV test uptake.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Center for Disease Control and Prevention HIV Surveillance Supplemental Report: Estimated HIV Incidence and Prevalence in the United States, 2018–20222024 Available at: https://stacks.cdc.gov/view/cdc/156513 Accessed June 1, 2024
